These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 22015609)

  • 21. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain-derived neurotrophic factor modified human umbilical cord mesenchymal stem cells-derived cholinergic-like neurons improve spatial learning and memory ability in Alzheimer's disease rats.
    Hu W; Feng Z; Xu J; Jiang Z; Feng M
    Brain Res; 2019 May; 1710():61-73. PubMed ID: 30586546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.
    Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS
    Front Immunol; 2018; 9():1078. PubMed ID: 29892282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo monitoring of dynamic interaction between neutrophil and human umbilical cord blood-derived mesenchymal stem cell in mouse liver during sepsis.
    Ahn SY; Maeng YS; Kim YR; Choe YH; Hwang HS; Hyun YM
    Stem Cell Res Ther; 2020 Feb; 11(1):44. PubMed ID: 32014040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of human umbilical cord blood-derived mesenchymal stem cells in the Alzheimer's disease transgenic mouse after a single intravenous injection.
    Park SE; Lee NK; Lee J; Hwang JW; Choi SJ; Hwang H; Hyung B; Chang JW; Na DL
    Neuroreport; 2016 Mar; 27(4):235-41. PubMed ID: 26752148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes.
    Katsuda T; Tsuchiya R; Kosaka N; Yoshioka Y; Takagaki K; Oki K; Takeshita F; Sakai Y; Kuroda M; Ochiya T
    Sci Rep; 2013; 3():1197. PubMed ID: 23378928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-cadherin determines individual variations in the therapeutic efficacy of human umbilical cord blood-derived mesenchymal stem cells in a rat model of myocardial infarction.
    Lee EJ; Choi EK; Kang SK; Kim GH; Park JY; Kang HJ; Lee SW; Kim KH; Kwon JS; Lee KH; Ahn Y; Lee HJ; Cho HJ; Choi SJ; Oh WI; Park YB; Kim HS
    Mol Ther; 2012 Jan; 20(1):155-67. PubMed ID: 22068423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The exosome of adipose-derived stem cells reduces β-amyloid pathology and apoptosis of neuronal cells derived from the transgenic mouse model of Alzheimer's disease.
    Lee M; Ban JJ; Yang S; Im W; Kim M
    Brain Res; 2018 Jul; 1691():87-93. PubMed ID: 29625119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic effect of long-interval repeated intravenous administration of human umbilical cord blood-derived mesenchymal stem cells in DBA/1 mice with collagen-induced arthritis.
    Yu Y; Yoon KA; Kang TW; Jeon HJ; Sim YB; Choe SH; Baek SY; Lee S; Seo KW; Kang KS
    J Tissue Eng Regen Med; 2019 Jul; 13(7):1134-1142. PubMed ID: 30959558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer's Disease.
    Kawanishi S; Takata K; Itezono S; Nagayama H; Konoya S; Chisaki Y; Toda Y; Nakata S; Yano Y; Kitamura Y; Ashihara E
    J Alzheimers Dis; 2018; 64(2):563-585. PubMed ID: 29914020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell surface expression of the major amyloid-β peptide (Aβ)-degrading enzyme, neprilysin, depends on phosphorylation by mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK) and dephosphorylation by protein phosphatase 1a.
    Kakiya N; Saito T; Nilsson P; Matsuba Y; Tsubuki S; Takei N; Nawa H; Saido TC
    J Biol Chem; 2012 Aug; 287(35):29362-72. PubMed ID: 22767595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stem cell-derived extracellular vesicles ameliorate Alzheimer's disease-like phenotypes in a preclinical mouse model.
    Cone AS; Yuan X; Sun L; Duke LC; Vreones MP; Carrier AN; Kenyon SM; Carver SR; Benthem SD; Stimmell AC; Moseley SC; Hike D; Grant SC; Wilber AA; Olcese JM; Meckes DG
    Theranostics; 2021; 11(17):8129-8142. PubMed ID: 34373732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of ICAM1 in Brain Vessels is Implicated in an Early AD Pathogenesis by Modulating Neprilysin.
    Otgongerel D; Lee HJ; Jo SA
    Neuromolecular Med; 2023 Jun; 25(2):193-204. PubMed ID: 35948857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Administrations of human adult ischemia-tolerant mesenchymal stem cells and factors reduce amyloid beta pathology in a mouse model of Alzheimer's disease.
    Harach T; Jammes F; Muller C; Duthilleul N; Cheatham V; Zufferey V; Cheatham D; Lukasheva YA; Lasser T; Bolmont T
    Neurobiol Aging; 2017 Mar; 51():83-96. PubMed ID: 28056358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracerebral Injection of Extracellular Vesicles from Mesenchymal Stem Cells Exerts Reduced Aβ Plaque Burden in Early Stages of a Preclinical Model of Alzheimer's Disease.
    Elia CA; Tamborini M; Rasile M; Desiato G; Marchetti S; Swuec P; Mazzitelli S; Clemente F; Anselmo A; Matteoli M; Malosio ML; Coco S
    Cells; 2019 Sep; 8(9):. PubMed ID: 31510042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous administration of mesenchymal stem cells reduces Tau phosphorylation and inflammation in the 3xTg-AD mouse model of Alzheimer's disease.
    Neves AF; Camargo C; Premer C; Hare JM; Baumel BS; Pinto M
    Exp Neurol; 2021 Jul; 341():113706. PubMed ID: 33757765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic Effects of Transplantation of As-MiR-937-Expressing Mesenchymal Stem Cells in Murine Model of Alzheimer's Disease.
    Liu Z; Wang C; Wang X; Xu S
    Cell Physiol Biochem; 2015; 37(1):321-30. PubMed ID: 26316079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human umbilical cord mesenchymal stem cell-derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an AβPP/PS1 transgenic mouse model.
    Yang H; Xie Z; Wei L; Yang H; Yang S; Zhu Z; Wang P; Zhao C; Bi J
    Stem Cell Res Ther; 2013 Jul; 4(4):76. PubMed ID: 23826983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stem cells enhance autophagy and increase β-amyloid clearance in Alzheimer disease models.
    Shin JY; Park HJ; Kim HN; Oh SH; Bae JS; Ha HJ; Lee PH
    Autophagy; 2014 Jan; 10(1):32-44. PubMed ID: 24149893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.
    Marr RA; Rockenstein E; Mukherjee A; Kindy MS; Hersh LB; Gage FH; Verma IM; Masliah E
    J Neurosci; 2003 Mar; 23(6):1992-6. PubMed ID: 12657655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.